Small-cap funds led SIP collections at ₹5,012 crore, followed by mid-cap and flexi-cap schemes, as four equity categories together garnered ₹16,096 crore

SIP, MUTUAL FUND

Business Standard

Market investors would track any implications arising from US President Donald Trump signing the Sanctioning Russia and Iran Act, with crude oil and geopolitical developments remaining the key driving trends for equities this week, analysts said.
Besides, trading activity of foreign investors and trends in global markets would also be tracked, they added.
"Indian equities enter the coming week with crude oil, global bond yields and geopolitical developments likely to remain the main drivers of sentiment. A new source of uncertainty for Indian markets is emerging on the trade front.
"US President Donald Trump has signed into law legislation giving his administration expanded powers to impose tariffs of up to 100 per cent on imports from major buyers of Russian oil and gas, with India among the countries potentially exposed given its significant purchases of Russian crude," Ponmudi R, CEO - Enrich Money, an online trading and wealth tech firm, said.
US President Donald Trump signed t

BSE, stock market

Investors will track crude prices, global bond yields, FPI activity and implications of the US law allowing tariffs on buyers of Russian oil and gas

Press Trust of India

FPIs sell ₹23,676 crore in the secondary market, analysts see scope for a Nifty recovery, and grey-market premiums signal divergent IPO prospects this week

street sign

Tata Sons did not secure affirmative support of nominees: Tata Trusts

N Chandrasekaran

Seven out of its 16 unlisted subsidiaries reported a net loss in FY26 led by Air India

Tata Sons loss making subsidiaries reported combined net loss

The top 10 in August included Sun Pharma, Cipla, Abbott, Mankind Pharma, Torrent Pharmaceuticals, Alkem Laboratories, Intas Pharmaceuticals, Lupin, Zydus Lifesciences and Dr Reddy's Laboratories

pharma, pharmacy, capsule

RBI order on Tata Sons listing has provided 'full clarity', Mistry says a day after Noel Tata opposed any such move

Shapoorji Pallonji Group Chairman Shapoor Mistry

Tata Sons' board vote on N Chandrasekaran's reappointment and the mandatory listing has renewed questions over governance, board authority and Tata Trusts' rights

Tata Sons, Tata group, bombay house

Tata Sons cleared N. Chandrasekaran's five-year reappointment and its proposed listing. Tata Trusts has opposed both the reappointment and listing, citing the Trusts' public-purpose role in the group.

Tata stocks retreat up to 8% as rift widens on listing, Chandra's term

The board backed the listing proposal despite opposition from Tata Trusts chairman Noel Tata and approved another five-year term for N Chandrasekaran

Natarajan Chandrasekaran, chairman of Tata Sons Ltd

Stay updated with the latest stock market news and live updates. Get real-time insights on Sensex Today, Nifty Live, stock market today, IPO news and more on Business Standard.

Share Market Today | Latest Stock Market News, Sensex Today and Nifty Live Updates

Stay updated with the latest stock market news and live updates. Get real-time insights on Sensex, Nifty, stock market today, IPO news, mutual funds, and more on Business Standard.